Use of a baseline risk score to identify the risk of serious infectious events in patients with rheumatoid arthritis during certolizumab pegol treatment

The risk of serious infectious events (SIEs) is increased in patients with rheumatoid arthritis (RA). The aim of this study was to develop an age-adjusted comorbidity index (AACI) to predict, using baseline ch...

Source: Arthritis Research and Therapy - December 15, 2017 Category: Rheumatology Authors: Jeffrey R. Curtis, Kevin Winthrop, Cathy O ’Brien, Matladi N. Ndlovu, Marc de Longueville and Boulos Haraoui Tags: Research article Source Type: research